ACE2 gene combined with exercise training attenuates central AngII/AT1 axis function and oxidative stress in a prehypertensive rat model

Angiotensin-converting enzyme 2 (ACE2) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted baroreflex sensitivity (BRS) and inhibiting sympathetic nerve activity (SNA). Its underlying mechanism may be related to the inhibition of AngII...

Full description

Saved in:
Bibliographic Details
Published inJournal of applied physiology (1985) Vol. 132; no. 6; pp. 1460 - 1467
Main Authors Chen, Xiu-Yun, Lin, Cheng, Liu, Guo-Ying, Pei, Chun, Xu, Gui-Qing, Gao, Lie, Wang, Shi-Zhong, Pan, Yan-Xia
Format Journal Article
LanguageEnglish
Published United States American Physiological Society 01.06.2022
SeriesPhysical Activity and the Brain
Subjects
Online AccessGet full text
ISSN8750-7587
1522-1601
1522-1601
DOI10.1152/japplphysiol.00459.2021

Cover

Loading…
Abstract Angiotensin-converting enzyme 2 (ACE2) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted baroreflex sensitivity (BRS) and inhibiting sympathetic nerve activity (SNA). Its underlying mechanism may be related to the inhibition of AngII/AT1 axis function and central oxidative stress in the paraventricular nucleus (PVN) of prehypertensive rats. Angiotensin-converting enzyme 2 (ACE2) or exercise training (ExT) is beneficial to hypertension, but their combined effects remain unknown. In this study, lentivirus containing enhanced green fluorescent protein (eGFP) and ACE2 were microinjected into the paraventricular nucleus (PVN) of young male spontaneous hypertensive rats (SHRs), and SHRs were assigned into five groups: sedentary (SHR), SHR-ExT, SHR-eGFP, ACE2 gene (SHR-ACE2), and ACE2 gene combined with ExT (SHR-ACE2-ExT). Wistar–Kyoto (WKY) rats were used as a control. ACE2 gene or ExT significantly delayed the elevation of blood pressure, and the combined effect prevented the development and progression of prehypertension. Either ACE2 overexpression or ExT improved arterial baroreflex sensitivity (BRS), whereas the combined effect normalized BRS in SHR. Compared with SHR, SHR-ACE2 and SHR-ExT displayed a significantly higher level of ACE2 protein but had lower plasma norepinephrine (NE) and angiotensin II (AngII) as well as angiotensin II type 1 receptor (AT1) protein expression in the PVN. SHR-ACE2-ExT showed the largest decrease in AngII and AT1 protein expression. Reactive oxygen species (ROS) level and NADPH oxidase (NOX2 and NOX4) protein expression in PVN were also decreased in SHR-ACE2-ExT group than in SHR-ACE2 and SHR-ExT groups. It was concluded that the combined effect has effectively prevented prehypertension progression and baroreflex dysfunction in SHR, which is associated with the reduction in AngII/AT1 axis function and oxidative stress in the PVN. NEW & NOTEWORTHY Angiotensin-converting enzyme 2 ( ACE2) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted baroreflex sensitivity (BRS) and inhibiting sympathetic nerve activity (SNA). Its underlying mechanism may be related to the inhibition of AngII/AT1 axis function and central oxidative stress in the paraventricular nucleus (PVN) of prehypertensive rats.
AbstractList Angiotensin-converting enzyme 2 (ACE2) or exercise training (ExT) is beneficial to hypertension, but their combined effects remain unknown. In this study, lentivirus containing enhanced green fluorescent protein (eGFP) and were microinjected into the paraventricular nucleus (PVN) of young male spontaneous hypertensive rats (SHRs), and SHRs were assigned into five groups: sedentary (SHR), SHR-ExT, SHR-eGFP, gene (SHR-ACE2), and gene combined with ExT (SHR-ACE2-ExT). Wistar-Kyoto (WKY) rats were used as a control. gene or ExT significantly delayed the elevation of blood pressure, and the combined effect prevented the development and progression of prehypertension. Either overexpression or ExT improved arterial baroreflex sensitivity (BRS), whereas the combined effect normalized BRS in SHR. Compared with SHR, SHR-ACE2 and SHR-ExT displayed a significantly higher level of ACE2 protein but had lower plasma norepinephrine (NE) and angiotensin II (AngII) as well as angiotensin II type 1 receptor (AT1) protein expression in the PVN. SHR-ACE2-ExT showed the largest decrease in AngII and AT1 protein expression. Reactive oxygen species (ROS) level and NADPH oxidase (NOX2 and NOX4) protein expression in PVN were also decreased in SHR-ACE2-ExT group than in SHR-ACE2 and SHR-ExT groups. It was concluded that the combined effect has effectively prevented prehypertension progression and baroreflex dysfunction in SHR, which is associated with the reduction in AngII/AT1 axis function and oxidative stress in the PVN. Angiotensin-converting enzyme 2 ( ) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted baroreflex sensitivity (BRS) and inhibiting sympathetic nerve activity (SNA). Its underlying mechanism may be related to the inhibition of AngII/AT1 axis function and central oxidative stress in the paraventricular nucleus (PVN) of prehypertensive rats.
Angiotensin-converting enzyme 2 (ACE2) or exercise training (ExT) is beneficial to hypertension, but their combined effects remain unknown. In this study, lentivirus containing enhanced green fluorescent protein (eGFP) and ACE2 were microinjected into the paraventricular nucleus (PVN) of young male spontaneous hypertensive rats (SHRs), and SHRs were assigned into five groups: sedentary (SHR), SHR-ExT, SHR-eGFP, ACE2 gene (SHR-ACE2), and ACE2 gene combined with ExT (SHR-ACE2-ExT). Wistar-Kyoto (WKY) rats were used as a control. ACE2 gene or ExT significantly delayed the elevation of blood pressure, and the combined effect prevented the development and progression of prehypertension. Either ACE2 overexpression or ExT improved arterial baroreflex sensitivity (BRS), whereas the combined effect normalized BRS in SHR. Compared with SHR, SHR-ACE2 and SHR-ExT displayed a significantly higher level of ACE2 protein but had lower plasma norepinephrine (NE) and angiotensin II (AngII) as well as angiotensin II type 1 receptor (AT1) protein expression in the PVN. SHR-ACE2-ExT showed the largest decrease in AngII and AT1 protein expression. Reactive oxygen species (ROS) level and NADPH oxidase (NOX2 and NOX4) protein expression in PVN were also decreased in SHR-ACE2-ExT group than in SHR-ACE2 and SHR-ExT groups. It was concluded that the combined effect has effectively prevented prehypertension progression and baroreflex dysfunction in SHR, which is associated with the reduction in AngII/AT1 axis function and oxidative stress in the PVN.NEW & NOTEWORTHY Angiotensin-converting enzyme 2 (ACE2) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted baroreflex sensitivity (BRS) and inhibiting sympathetic nerve activity (SNA). Its underlying mechanism may be related to the inhibition of AngII/AT1 axis function and central oxidative stress in the paraventricular nucleus (PVN) of prehypertensive rats.Angiotensin-converting enzyme 2 (ACE2) or exercise training (ExT) is beneficial to hypertension, but their combined effects remain unknown. In this study, lentivirus containing enhanced green fluorescent protein (eGFP) and ACE2 were microinjected into the paraventricular nucleus (PVN) of young male spontaneous hypertensive rats (SHRs), and SHRs were assigned into five groups: sedentary (SHR), SHR-ExT, SHR-eGFP, ACE2 gene (SHR-ACE2), and ACE2 gene combined with ExT (SHR-ACE2-ExT). Wistar-Kyoto (WKY) rats were used as a control. ACE2 gene or ExT significantly delayed the elevation of blood pressure, and the combined effect prevented the development and progression of prehypertension. Either ACE2 overexpression or ExT improved arterial baroreflex sensitivity (BRS), whereas the combined effect normalized BRS in SHR. Compared with SHR, SHR-ACE2 and SHR-ExT displayed a significantly higher level of ACE2 protein but had lower plasma norepinephrine (NE) and angiotensin II (AngII) as well as angiotensin II type 1 receptor (AT1) protein expression in the PVN. SHR-ACE2-ExT showed the largest decrease in AngII and AT1 protein expression. Reactive oxygen species (ROS) level and NADPH oxidase (NOX2 and NOX4) protein expression in PVN were also decreased in SHR-ACE2-ExT group than in SHR-ACE2 and SHR-ExT groups. It was concluded that the combined effect has effectively prevented prehypertension progression and baroreflex dysfunction in SHR, which is associated with the reduction in AngII/AT1 axis function and oxidative stress in the PVN.NEW & NOTEWORTHY Angiotensin-converting enzyme 2 (ACE2) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted baroreflex sensitivity (BRS) and inhibiting sympathetic nerve activity (SNA). Its underlying mechanism may be related to the inhibition of AngII/AT1 axis function and central oxidative stress in the paraventricular nucleus (PVN) of prehypertensive rats.
Angiotensin-converting enzyme 2 (ACE2) or exercise training (ExT) is beneficial to hypertension, but their combined effects remain unknown. In this study, lentivirus containing enhanced green fluorescent protein (eGFP) and ACE2 were microinjected into the paraventricular nucleus (PVN) of young male spontaneous hypertensive rats (SHRs), and SHRs were assigned into five groups: sedentary (SHR), SHR-ExT, SHR-eGFP, ACE2 gene (SHR-ACE2), and ACE2 gene combined with ExT (SHR-ACE2-ExT). Wistar–Kyoto (WKY) rats were used as a control. ACE2 gene or ExT significantly delayed the elevation of blood pressure, and the combined effect prevented the development and progression of prehypertension. Either ACE2 overexpression or ExT improved arterial baroreflex sensitivity (BRS), whereas the combined effect normalized BRS in SHR. Compared with SHR, SHR-ACE2 and SHR-ExT displayed a significantly higher level of ACE2 protein but had lower plasma norepinephrine (NE) and angiotensin II (AngII) as well as angiotensin II type 1 receptor (AT1) protein expression in the PVN. SHR-ACE2-ExT showed the largest decrease in AngII and AT1 protein expression. Reactive oxygen species (ROS) level and NADPH oxidase (NOX2 and NOX4) protein expression in PVN were also decreased in SHR-ACE2-ExT group than in SHR-ACE2 and SHR-ExT groups. It was concluded that the combined effect has effectively prevented prehypertension progression and baroreflex dysfunction in SHR, which is associated with the reduction in AngII/AT1 axis function and oxidative stress in the PVN. NEW & NOTEWORTHY Angiotensin-converting enzyme 2 ( ACE2 ) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted baroreflex sensitivity (BRS) and inhibiting sympathetic nerve activity (SNA). Its underlying mechanism may be related to the inhibition of AngII/AT1 axis function and central oxidative stress in the paraventricular nucleus (PVN) of prehypertensive rats.
Angiotensin-converting enzyme 2 (ACE2) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted baroreflex sensitivity (BRS) and inhibiting sympathetic nerve activity (SNA). Its underlying mechanism may be related to the inhibition of AngII/AT1 axis function and central oxidative stress in the paraventricular nucleus (PVN) of prehypertensive rats. Angiotensin-converting enzyme 2 (ACE2) or exercise training (ExT) is beneficial to hypertension, but their combined effects remain unknown. In this study, lentivirus containing enhanced green fluorescent protein (eGFP) and ACE2 were microinjected into the paraventricular nucleus (PVN) of young male spontaneous hypertensive rats (SHRs), and SHRs were assigned into five groups: sedentary (SHR), SHR-ExT, SHR-eGFP, ACE2 gene (SHR-ACE2), and ACE2 gene combined with ExT (SHR-ACE2-ExT). Wistar–Kyoto (WKY) rats were used as a control. ACE2 gene or ExT significantly delayed the elevation of blood pressure, and the combined effect prevented the development and progression of prehypertension. Either ACE2 overexpression or ExT improved arterial baroreflex sensitivity (BRS), whereas the combined effect normalized BRS in SHR. Compared with SHR, SHR-ACE2 and SHR-ExT displayed a significantly higher level of ACE2 protein but had lower plasma norepinephrine (NE) and angiotensin II (AngII) as well as angiotensin II type 1 receptor (AT1) protein expression in the PVN. SHR-ACE2-ExT showed the largest decrease in AngII and AT1 protein expression. Reactive oxygen species (ROS) level and NADPH oxidase (NOX2 and NOX4) protein expression in PVN were also decreased in SHR-ACE2-ExT group than in SHR-ACE2 and SHR-ExT groups. It was concluded that the combined effect has effectively prevented prehypertension progression and baroreflex dysfunction in SHR, which is associated with the reduction in AngII/AT1 axis function and oxidative stress in the PVN. NEW & NOTEWORTHY Angiotensin-converting enzyme 2 ( ACE2) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted baroreflex sensitivity (BRS) and inhibiting sympathetic nerve activity (SNA). Its underlying mechanism may be related to the inhibition of AngII/AT1 axis function and central oxidative stress in the paraventricular nucleus (PVN) of prehypertensive rats.
Angiotensin-converting enzyme 2 (ACE2) or exercise training (ExT) is beneficial to hypertension, but their combined effects remain unknown. In this study, lentivirus containing enhanced green fluorescent protein (eGFP) and ACE2 were microinjected into the paraventricular nucleus (PVN) of young male spontaneous hypertensive rats (SHRs), and SHRs were assigned into five groups: sedentary (SHR), SHR-ExT, SHR-eGFP, ACE2 gene (SHR-ACE2), and ACE2 gene combined with ExT (SHR-ACE2-ExT). Wistar–Kyoto (WKY) rats were used as a control. ACE2 gene or ExT significantly delayed the elevation of blood pressure, and the combined effect prevented the development and progression of prehypertension. Either ACE2 overexpression or ExT improved arterial baroreflex sensitivity (BRS), whereas the combined effect normalized BRS in SHR. Compared with SHR, SHR-ACE2 and SHR-ExT displayed a significantly higher level of ACE2 protein but had lower plasma norepinephrine (NE) and angiotensin II (AngII) as well as angiotensin II type 1 receptor (AT1) protein expression in the PVN. SHR-ACE2-ExT showed the largest decrease in AngII and AT1 protein expression. Reactive oxygen species (ROS) level and NADPH oxidase (NOX2 and NOX4) protein expression in PVN were also decreased in SHR-ACE2-ExT group than in SHR-ACE2 and SHR-ExT groups. It was concluded that the combined effect has effectively prevented prehypertension progression and baroreflex dysfunction in SHR, which is associated with the reduction in AngII/AT1 axis function and oxidative stress in the PVN.
Author Liu, Guo-Ying
Chen, Xiu-Yun
Pei, Chun
Xu, Gui-Qing
Lin, Cheng
Gao, Lie
Wang, Shi-Zhong
Pan, Yan-Xia
Author_xml – sequence: 1
  givenname: Xiu-Yun
  orcidid: 0000-0002-1025-2290
  surname: Chen
  fullname: Chen, Xiu-Yun
  organization: Department of Rehabilitation Medicine, Health School of Fujian Medical University, Fuzhou, China
– sequence: 2
  givenname: Cheng
  surname: Lin
  fullname: Lin, Cheng
  organization: Department of Rehabilitation Medicine, Health School of Fujian Medical University, Fuzhou, China
– sequence: 3
  givenname: Guo-Ying
  surname: Liu
  fullname: Liu, Guo-Ying
  organization: Department of Rehabilitation Medicine, Health School of Fujian Medical University, Fuzhou, China
– sequence: 4
  givenname: Chun
  surname: Pei
  fullname: Pei, Chun
  organization: Department of Rehabilitation Medicine, Health School of Fujian Medical University, Fuzhou, China
– sequence: 5
  givenname: Gui-Qing
  surname: Xu
  fullname: Xu, Gui-Qing
  organization: Department of Rehabilitation Medicine, Health School of Fujian Medical University, Fuzhou, China
– sequence: 6
  givenname: Lie
  surname: Gao
  fullname: Gao, Lie
  organization: Department of Cellular and Integrative, Physiology of University of Nebraska Medical Center, Omaha, Nebraska
– sequence: 7
  givenname: Shi-Zhong
  surname: Wang
  fullname: Wang, Shi-Zhong
  organization: Department of Rehabilitation Medicine, Health School of Fujian Medical University, Fuzhou, China
– sequence: 8
  givenname: Yan-Xia
  orcidid: 0000-0002-0570-4117
  surname: Pan
  fullname: Pan, Yan-Xia
  organization: Department of Rehabilitation Medicine, Health School of Fujian Medical University, Fuzhou, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35546127$$D View this record in MEDLINE/PubMed
BookMark eNqFUsFuEzEQtVARTQu_AJa4cNnU9nrt3QNCUVQgUiUuuVte7yRxtLEX29smf8Bn46WhKr1wsjzvzZs3mneFLpx3gNAHSuaUVuxmr4ehH3anaH0_J4RXzZwRRl-hWUZZQQWhF2hWy4oUsqrlJbqKcU8I5byib9BlWVVcUCZn6NdiecvwFhxg4w-tddDhB5t2GI4QjI2AU9DWWbfFOiVwo04QsQGXyz1euO1qdbNYU6yPNuLN6Eyy3mHtOuyPttPJ3gOOKUCM2OY6HgLsTgOELBUnLOiED76D_i16vdF9hHfn9xqtv96ul9-Lux_fVsvFXWE4F6noOk5pw0F3NZQcGkFFIwxjQlYtASnzj0lO2EaWujWacEbaUvNWyFp2JSmv0ZdH2WFsD9CdF1FDsAcdTsprq_5FnN2prb9XeSqtOZdZ4dNZIfifI8SkDjYa6HvtwI9RMSG4bHjDaaZ-fEHd-zG4vJ6aDGevNSkz6_1zS09e_h4pE-QjwQQfY4DNE4USNcVBPY-D-hMHNcUhd35-0Wls0tOJpqv2_-3_DRAJwsg
CitedBy_id crossref_primary_10_1152_japplphysiol_00736_2022
crossref_primary_10_1038_s41440_023_01480_y
crossref_primary_10_3390_ijms26062822
Cites_doi 10.1371/journal.pone.0022682
10.1371/journal.pone.0094927
10.3389/fnins.2018.00493
10.1161/01.HYP.0000256955.74461.93
10.1161/HYPERTENSIONAHA.110.164244
10.1093/eurheartj/ehaa605
10.1152/ajpheart.00349.2015
10.1016/j.autneu.2017.09.012
10.1152/ajpregu.00222.2010
10.1139/apnm-2014-0351
10.1161/01.HYP.0000259942.38108.20
10.1161/HYPERTENSIONAHA.115.03624
10.1002/phy2.264
10.1007/s12264-018-0316-5
10.1161/CIRCRESAHA.109.208645
10.1161/HYPERTENSIONAHA.117.09600
10.1093/cvr/cvr242
10.1161/CIRCULATIONAHA.110.955369
10.1113/expphysiol.2008.046128
10.1161/HYPERTENSIONAHA.111.176636
10.1152/ajpheart.00330.2011
10.1016/j.brainres.2019.02.004
10.1113/expphysiol.2012.067165
10.1097/MNH.0b013e328341164a
10.1152/ajpregu.00366.2014
10.1249/MSS.0000000000002263
10.1590/1414-431X20165349
10.1155/2016/7413963
10.1097/HJH.0b013e328305e1a5
10.3109/10641963.2012.681084
10.1161/HYPERTENSIONAHA.106.085548
10.1161/STROKEAHA.112.667063
ContentType Journal Article
Copyright Copyright American Physiological Society Jun 2022
Copyright © 2022 the American Physiological Society. 2022 American Physiological Society
Copyright_xml – notice: Copyright American Physiological Society Jun 2022
– notice: Copyright © 2022 the American Physiological Society. 2022 American Physiological Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7TK
7TS
7U7
8FD
C1K
FR3
P64
7X8
5PM
DOI 10.1152/japplphysiol.00459.2021
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Neurosciences Abstracts
Physical Education Index
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Technology Research Database
Toxicology Abstracts
Chemoreception Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Physical Education Index
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

CrossRef
Technology Research Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
DocumentTitleAlternate BENEFITS OF ACE2 COMBINED WITH ExT IN PREHYPERTENSION
EISSN 1522-1601
EndPage 1467
ExternalDocumentID PMC11918447
35546127
10_1152_japplphysiol_00459_2021
Genre Journal Article
GrantInformation_xml – fundername: Youth Found of Fujian Medical University
  grantid: 2014MP025
– fundername: NHLBI NIH HHS
  grantid: R01 HL160820
– fundername: National Natural Science Foundation of China (NSFC)
  grantid: 81372111
GroupedDBID ---
-~X
.55
18M
29J
2WC
4.4
53G
5VS
85S
AAFWJ
AAYXX
ABCQX
ABDNZ
ABHWK
ABJNI
ABKWE
ABOCM
ACBEA
ACGFO
ACGFS
ACIWK
ACPRK
ADBBV
ADFNX
AEILP
AENEX
AFOSN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BKKCC
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
EMOBN
F5P
FRP
GX1
H13
H~9
ITBOX
KQ8
L7B
OK1
P2P
P6G
PQQKQ
RAP
RHI
RPL
RPRKH
SJN
TR2
UHB
UKR
UPT
W8F
WH7
WOQ
X7M
XSW
YBH
YQT
YWH
~02
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7TK
7TS
7U7
8FD
C1K
FR3
P64
7X8
5PM
ID FETCH-LOGICAL-c446t-dd41194ead8e34e961696c22675b0e7769627402f73abca0420b3a4b6787d303
ISSN 8750-7587
1522-1601
IngestDate Thu Aug 21 18:39:21 EDT 2025
Fri Sep 05 09:35:33 EDT 2025
Mon Jun 30 10:38:16 EDT 2025
Fri Mar 21 01:26:05 EDT 2025
Tue Jul 01 03:17:03 EDT 2025
Thu Apr 24 23:01:18 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords baroreflex
hypertension
renin-angiotensin system
exercise training
paraventricular nucleus
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c446t-dd41194ead8e34e961696c22675b0e7769627402f73abca0420b3a4b6787d303
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
X.-Y. Chen and C. Lin contributed equally to this work.
ORCID 0000-0002-1025-2290
0000-0002-0570-4117
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/11918447
PMID 35546127
PQID 2675696803
PQPubID 40905
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11918447
proquest_miscellaneous_2664794941
proquest_journals_2675696803
pubmed_primary_35546127
crossref_primary_10_1152_japplphysiol_00459_2021
crossref_citationtrail_10_1152_japplphysiol_00459_2021
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-06-01
PublicationDateYYYYMMDD 2022-06-01
PublicationDate_xml – month: 06
  year: 2022
  text: 2022-06-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Bethesda
– name: Rockville, MD
PublicationSeriesTitle Physical Activity and the Brain
PublicationTitle Journal of applied physiology (1985)
PublicationTitleAlternate J Appl Physiol (1985)
PublicationYear 2022
Publisher American Physiological Society
Publisher_xml – name: American Physiological Society
References B20
B23
B24
B25
B27
B28
B29
Zhao XL (B8) 2018; 34
Pan YX (B22) 2014; 23
B30
B31
B10
B32
B11
B33
B12
B34
B13
B35
B14
Paxinos G (B21) 2005
B36
B15
B16
B38
B17
B18
Peng WW (B37) 2019; 35
B19
B2
B3
B4
B5
B6
B7
B9
Liu GY (B26) 2021; 37
Ghadieh AS (B1) 2015; 61
References_xml – ident: B35
  doi: 10.1371/journal.pone.0022682
– ident: B5
  doi: 10.1371/journal.pone.0094927
– ident: B29
  doi: 10.3389/fnins.2018.00493
– volume: 37
  start-page: 218
  year: 2021
  ident: B26
  publication-title: Chin J Pathophysiol
– ident: B33
  doi: 10.1161/01.HYP.0000256955.74461.93
– ident: B34
  doi: 10.1161/HYPERTENSIONAHA.110.164244
– volume: 23
  start-page: 364
  year: 2014
  ident: B22
  publication-title: Chin J Cardiovasc Rehab Med
– ident: B2
  doi: 10.1093/eurheartj/ehaa605
– ident: B27
  doi: 10.1152/ajpheart.00349.2015
– ident: B28
  doi: 10.1016/j.autneu.2017.09.012
– ident: B10
  doi: 10.1152/ajpregu.00222.2010
– ident: B4
  doi: 10.1139/apnm-2014-0351
– ident: B11
  doi: 10.1161/01.HYP.0000259942.38108.20
– ident: B15
  doi: 10.1161/HYPERTENSIONAHA.115.03624
– ident: B36
  doi: 10.1002/phy2.264
– ident: B9
  doi: 10.1007/s12264-018-0316-5
– ident: B14
  doi: 10.1161/CIRCRESAHA.109.208645
– ident: B18
  doi: 10.1161/HYPERTENSIONAHA.117.09600
– ident: B19
  doi: 10.1093/cvr/cvr242
– ident: B20
  doi: 10.1161/CIRCULATIONAHA.110.955369
– ident: B6
  doi: 10.1113/expphysiol.2008.046128
– ident: B31
  doi: 10.1161/HYPERTENSIONAHA.111.176636
– ident: B32
  doi: 10.1152/ajpheart.00330.2011
– ident: B38
  doi: 10.1016/j.brainres.2019.02.004
– ident: B16
  doi: 10.1113/expphysiol.2012.067165
– ident: B12
  doi: 10.1097/MNH.0b013e328341164a
– ident: B13
  doi: 10.1152/ajpregu.00366.2014
– volume: 35
  start-page: 1081
  year: 2019
  ident: B37
  publication-title: Chin J Pathophysiol
– ident: B23
  doi: 10.1249/MSS.0000000000002263
– ident: B24
  doi: 10.1590/1414-431X20165349
– ident: B25
  doi: 10.1155/2016/7413963
– volume: 61
  start-page: 233
  year: 2015
  ident: B1
  publication-title: Can Fam Physician
– ident: B7
  doi: 10.1097/HJH.0b013e328305e1a5
– ident: B30
  doi: 10.3109/10641963.2012.681084
– volume: 34
  start-page: 35
  year: 2018
  ident: B8
  publication-title: Chin J Pathophysiol
– volume-title: The Rat Brain in Stereotaxic Coordinates
  year: 2005
  ident: B21
– ident: B3
  doi: 10.1161/HYPERTENSIONAHA.106.085548
– ident: B17
  doi: 10.1161/STROKEAHA.112.667063
SSID ssj0014451
Score 2.4050353
Snippet Angiotensin-converting enzyme 2 (ACE2) gene in combination with exercise training (ExT) delayed the progression of hypertension via normalizing the blunted...
Angiotensin-converting enzyme 2 (ACE2) or exercise training (ExT) is beneficial to hypertension, but their combined effects remain unknown. In this study,...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1460
SubjectTerms ACE2
ACE2 gene
Angiotensin
Angiotensin I - metabolism
Angiotensin II
Angiotensin II - metabolism
Angiotensin-converting enzyme 2
Angiotensin-Converting Enzyme 2 - metabolism
Animal models
Animals
Baroreceptors
Blood Pressure
CYBB protein
Fitness training programs
Fluorescence
Green fluorescent protein
Hypertension
Hypertension - metabolism
Hypertension - therapy
Male
NAD(P)H oxidase
Norepinephrine
NOX4 protein
Oxidative stress
Oxidative Stress - physiology
Paraventricular Hypothalamic Nucleus
Paraventricular nucleus
Peptidyl-dipeptidase A
Physical Conditioning, Animal - physiology
Physical training
Prehypertension - metabolism
Pressure effects
Protein expression
Proteins
Rats
Rats, Inbred SHR
Rats, Inbred WKY
Reactive oxygen species
Reflexes
Title ACE2 gene combined with exercise training attenuates central AngII/AT1 axis function and oxidative stress in a prehypertensive rat model
URI https://www.ncbi.nlm.nih.gov/pubmed/35546127
https://www.proquest.com/docview/2675696803
https://www.proquest.com/docview/2664794941
https://pubmed.ncbi.nlm.nih.gov/PMC11918447
Volume 132
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIiEuCFoegYIWCXGJ3PqxXsfHKEppUVs4uFJ6smzvprVEbdTaUssv4Ffx25jZh52EltfFStb2er3zZXZmM_MNIe8EF8KXbOEU8UI4LCs8Z6xyZfI4yEIfIKMoNo6O-f4J-zgP54PBj6WopbbJd4pvt-aV_I9UoQ3kilmy_yDZrlNogM8gXziChOH4VzKeTGc-1kDGiPMLcHFtKLmto9QVgBghi2bVol05MuGYo0l1dnCAdAqJN8quy6sRLnGNjU6ur0uhOcFNNkkJ7cgocA6O66UNewf46Fo6d9i4mbFx1f6JZntCYqh4HC7tQExNgsi8bJ3Ttg8RKk08gDSLq2pr1UZ-WzunZd_8WZb6UnO32cUAB7iLtlpKHEC1b8ejIGoiV3udCN6V64CLo9doaXQ2dOdx05tV6v2u6ZqKhqXBvX3tCH1VswBmxszKDhq8mM2kk7hX2bqPP6V7J4eHaTKbJ_fIfT-KVJjAh3kXYuQh-ZveX9aDNvGF8KDdOx6zah394vKsR-4umULJY_LIyJdONCCfkIGsNsnWpMqa-uKGvqfd7N5skgdHJnhji3xHuFKEK7VwpQhXauFKLVxpD1dqxkAVXHcBrBTBSi1YKYCVdmClGqy0hHa6BlYKYKUKrE9JsjdLpvuOKQTiFIzxxhGCeV7MQOmNZcBkzD0e8wIchyjMXRlFXFWQcv1FFGR5kcE65OZBxnIwxCIBNtozslHVlXxBaBwIV-Q8X-QiYhms1kEBfcV-FuFXKYeE2_lPC0OSj-_-JVXOcuiny4JLleBSFNyQuN2NXzVPzJ9v2bYCTo1SuUrxnZCvyg2G5G13GlQ-_o-XVbJu8RqOdSFiBl0813jononuAzgt0ZCMV5DSXYB08qtnqvJc0coj1eOYsejl78f1ijzsf8DbZKO5bOVrMMyb_I1C_0_rMOtN
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=ACE2+gene+combined+with+exercise+training+attenuates+central+AngII%2FAT1+axis+function+and+oxidative+stress+in+a+prehypertensive+rat+model&rft.jtitle=Journal+of+applied+physiology+%281985%29&rft.au=Chen%2C+Xiu-Yun&rft.au=Lin%2C+Cheng&rft.au=Liu%2C+Guo-Ying&rft.au=Pei%2C+Chun&rft.date=2022-06-01&rft.pub=American+Physiological+Society&rft.issn=8750-7587&rft.eissn=1522-1601&rft.volume=132&rft.issue=6&rft.spage=1460&rft_id=info:doi/10.1152%2Fjapplphysiol.00459.2021&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=8750-7587&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=8750-7587&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=8750-7587&client=summon